InvestSMART

EZZ Life Science Holdings Limited (ASX:EZZ)

ALERT: Price-sensitive ASX Announcement for EZZ
Current share price for EZZ : $0.520 0.04 (8.33%)+
Announcement
Release
31 Jul 2026 3:49PM
Price at Release
$0.480
Full Release
download
Summary
EZZ Life Science Holdings Limited reported their quarterly activities and cash flow status, highlighting disciplined cash management and strategic growth efforts. Despite challenging conditions in offshore e-commerce, the company maintained a strong financial position with $9.7 million in cash and no debt (excluding lease liabilities). Key operational efforts included expanding the Australian pharmacy network and rolling out the MeTime product range through Woolworths HealthyLife. The board decided not to declare an interim dividend to preserve financial flexibility. EZZ plans to continue its growth strategy by focusing on product innovation, channel expansion, and international distribution. The report also detailed related party transactions and cash flow activities.
Key Points
  • Disciplined inventory management and cost control.
  • No interim dividend declared to preserve cash.
  • Cash and cash equivalents at $9.7 million; no debt.
  • Expansion of Australian pharmacy and MeTime range through Woolworths.
  • Operating cash outflow reduced to nearly breakeven.
  • Plans for FY27 focus on product innovation and distribution expansion.
  • Related party payments detailed for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.